Talphera, Inc. (TLPH)
NASDAQ: TLPH · Real-Time Price · USD
0.868
-0.007 (-0.83%)
At close: Mar 6, 2026, 4:00 PM EST
0.890
+0.023 (2.59%)
After-hours: Mar 6, 2026, 7:55 PM EST
Talphera Employees
Talphera had 13 employees as of December 31, 2024. The number of employees decreased by 2 or -13.33% compared to the previous year.
Employees
13
Change (1Y)
-2
Growth (1Y)
-13.33%
Revenue / Employee
$2,154
Profits / Employee
-$952,923
Market Cap
40.43M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| InterCure | 320 |
| Zhengye Biotechnology Holding | 277 |
| Rockwell Medical | 244 |
| Cumberland Pharmaceuticals | 91 |
| Aytu BioPharma | 83 |
| Assertio Holdings | 58 |
| BioXcel Therapeutics | 37 |
| SCYNEXIS | 28 |
TLPH News
- 5 days ago - Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-CRRT Registrational Trial - PRNewsWire
- 4 months ago - Talphera, Inc. (TLPH) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 4 months ago - Talphera to Host Third Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, November 12, 2025 - PRNewsWire
- 4 months ago - Talphera Announces the Appointment of Joe Todisco to Board of Directors - PRNewsWire
- 6 months ago - CorMedix Announces Strategic Minority Investment in Talphera - GlobeNewsWire
- 6 months ago - Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market - PRNewsWire
- 6 months ago - Talphera Announces Achievement of 17 Patient Enrollment Milestone in NEPHRO CRRT Pivotal Trial - PRNewsWire